Skip to content
MarketNewsAPI
Product Live news Screener Coverage Pricing
Docs Overview REST API WebSocket API MCP server
Resources Use cases Blog Changelog Status Compare Contact
Log in Get API key Dashboard
APPN$49.87-2.09(-4.02%)Appian Defense Cloud Achieves IL5 Authorization Across Department of War Operations Appian today announced that the Appian Defense Cloud (ADC) achieved Impact Level 5 (IL5) Provisional Authorization to Operate (PA) from the United...[11:00:00 AM ET]OSBC$24.63+0.22(+0.90%)O2 Sponsor Finance Hires James Benbrook as Vice President[11:00:00 AM ET]HOST$3.00+0.07(+2.39%)Before the Midterms, a Debate Over Where Data Centers Belong and Who Pays for Their Power[10:58:38 AM ET]VVOS$0.12-0.00(-1.56%)CORRECTION: SOD Sciences Welcomes Vivos Therapeutics as Strategic Investor and Partner in the ReBalU Primed Cell Test[10:52:00 AM ET]PPLL$61.17+1.17(+1.95%)Peoples Ltd. Declares Cash and Stock Dividend The Board of Directors of Peoples Ltd. (OTC: PPLL), the parent company of PS Bank, has declared a fourth quarter cash dividend of $0.36 per share and ...[10:44:00 AM ET]MSFT$524.08-6.93(-1.30%)Workhuman Achieves Industry-First Microsoft 365 Certification, Setting a New Standard for Employee Recognition Integrations[10:38:00 AM ET]LINC$22.07+0.35(+1.61%)Lincoln Tech Expands Career Training Program to Address New Jersey’s Skilled Labor Shortage[10:34:57 AM ET]FNF$40.46+1.16(+2.94%)IPX1031 Rolls Out “10-31 Day” Video Starring a Pumpkin with a Property to Pick[10:31:00 AM ET]CTEV$24.29+1.29(+5.61%)Claritev Introduces Transparency-Based Pricing, Turning Complex Public Market Data into Actionable Reimbursement Intelligence[10:30:00 AM ET]DAN$25.92+0.44(+1.73%)Dana Incorporated to Participate in Gabelli 50th Annual Automotive Symposium Dana Incorporated (NYSE: DAN) announced today it will participate in the Gabelli 50th Annual Automotive Symposium on November 3. Beginning at 4 p.m....[10:30:00 AM ET]

GMED · NYSE

Globus Medical, Inc.

$83.03 +1.73 (+2.13%)

Company overview

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative, deformity, tumor, and trauma conditions; treatment options for motion preservation technologies including dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional pain management solutions to treat vertebral compression fractures; and regenerative biologic products comprising allografts and synthetic alternatives.

Sector
Healthcare
Industry
Medical - Devices
Exchange
NYSE
Market cap
$11.1B
Employees
5,300
Headquarters
Audubon, PA
Website
globusmedical.com
CEO
Keith W. Pfeil
Listed
August 3, 2012
P/E
19.05
Dividend yield
0.00%

Company financials

Revenue
$3.1B
Gross profit
$2.1B
Operating income
$546M
EBITDA
$886M
Net income
$587M
EPS
$4.35
Total assets
$5.4B
Total debt
$115M
Gross margin
67.86%
Net margin
18.92%
Earnings yield
5.25%

Revenue segmentation

By product (FY 2025)

No annual product segmentation.

By region (FY 2025)

Showing FY 2025

Price chart

71.6277.8684.1190.3696.61
GMED 1D NYSE O80.47H81.75L80.23C81.30+0.40 (+0.49%)Vol187.04K

News

15-min delaySigned-out view is delayed 15 minutes. Log in on Pro for the live news desk.

Start 7-day free trial See live plans
Source
Date
Type
Ticker Type Headline Source Published
GMEDGlobus Medical, Inc. Stock news 2 Healthcare Technology Stocks for a Digital Health Boom Zacks Investment Research
GMEDGlobus Medical, Inc. Legal Kuehn Law Encourages Investors of Globus Medical, Inc. to Contact Law Firm Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Globus Medical, Inc. (NYSE: GMED)... PR Newswire
GMEDGlobus Medical, Inc. Stock news GMED or AXGN: Which Is the Better Value Stock Right Now? Zacks Investment Research
GMEDGlobus Medical, Inc. Press release Globus Medical to Showcase SCRIPT™ Patient-Specific Implants and New XLIF™ Prone Procedural Solution at NASS 2026 GlobeNewswire
GMEDGlobus Medical, Inc. Press release Globus Medical Schedules Third Quarter Earnings Release and Conference Call GlobeNewswire
GMEDGlobus Medical, Inc. Stock news Reasons to Add Globus Medical Stock to Your Portfolio Now Zacks Investment Research
GMEDGlobus Medical, Inc. Stock news Zacks Industry Outlook Globus Medical, Intuitive Surgical and Thermo Fisher Scientific Zacks Investment Research
GMEDGlobus Medical, Inc. Stock news Here's Why Globus Medical (GMED) is a Strong Value Stock Zacks Investment Research
GMEDGlobus Medical, Inc. Stock news 3 Medical Instruments Stocks Using GenAI to Navigate Industry Woes Zacks Investment Research
GMEDGlobus Medical, Inc. Stock news GMED vs. ITGR: Which Stock Is the Better Value Option? Zacks Investment Research
GMEDGlobus Medical, Inc. Stock news What Makes Globus Medical (GMED) a New Strong Buy Stock Zacks Investment Research
GMEDGlobus Medical, Inc. Stock news Top Robotics Stocks to Add to Your Portfolio for Impressive Returns Zacks Investment Research
GMEDGlobus Medical, Inc. Stock news GMED vs. ITGR: Which Stock Should Value Investors Buy Now? Zacks Investment Research
GMEDGlobus Medical, Inc. Stock news Why Globus Medical (GMED) is a Top Value Stock for the Long-Term Zacks Investment Research
GMEDGlobus Medical, Inc. Stock news New Strong Buy Stocks for September 11th Zacks Investment Research
GMEDGlobus Medical, Inc. Stock news 3 Medical Instruments Stocks Banking on GenAI to Tackle Industry Woes Zacks Investment Research
GMEDGlobus Medical, Inc. Stock news New Strong Buy Stocks for September 9th Zacks Investment Research
GMEDGlobus Medical, Inc. Press release Globus Medical Announces CE Mark for Excelsius3D™ Imaging System GlobeNewswire
GMEDGlobus Medical, Inc. Stock news 3 Reasons Growth Investors Will Love Globus Medical (GMED) Zacks Investment Research
GMEDGlobus Medical, Inc. Stock news Wall Street Analysts Believe Globus Medical (GMED) Could Rally 25.03%: Here's is How to Trade Zacks Investment Research
See more
FAQ

Questions about Globus Medical, Inc.

What does Globus Medical, Inc. do?
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative, deformity, tumor, and trauma conditions; treatment options for motion preservation technologies including dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional pain management solutions to treat vertebral compression fractures; and regenerative biologic products comprising allografts and synthetic alternatives.
What is GMED's market cap?
Globus Medical, Inc. (GMED) is a listed stock with a live quote. The latest market cap on this page is $11.1B.
Where is Globus Medical, Inc. headquartered?
Globus Medical, Inc. is headquartered in Audubon, PA.
How do I get GMED news from the API?
Call GET /v1/news?tickers=GMED. Add type=news, type=press_release, or type=legal to take one feed. Pro keys search the full archive in real time. Free keys are delayed 15 minutes and return the last year. Signed-out visitors and Free accounts see that same year on this page. Pro sees the full archive.
How far back does GMED news go?
Signed-out visitors and Free accounts see the last year of stock news, press releases, and legal notices for GMED, 15 minutes behind, and each headline links to the publisher. Pro, including the 7-day trial, sees the full archive as headlines are ingested. A Free API key returns the last year. Pro keys search the full archive.
Is the GMED price on this page from the API?
The price and daily change update during the US session for every visitor. That quote is context on this page. It is not part of the news API. The chart is one candle per session from the start of 2020. 1W, 1M, and 1Y group those sessions.
Can I use the Pro plan commercially?
No. The Pro plan cannot be used for commercial work. A product you sell, work you do for a client, or redistribution of the feed needs a custom plan and a license. Email [email protected].

Real-time stock news for $15 a month.

Start a 7-day Pro trial. A card is required. REST, WebSocket, and MCP are included, with 1,000 REST requests a day. You won't be charged during the trial. Unless you cancel, the card is billed for Pro when it ends.

Start 7-day free trial Read the docs